AL Amyloidosis Market Analysis 2025: Comprehensive Overview & Emerging Opportunities

24 Apr, 2025

The AL Amyloidosis Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.

What are the Historical Growth Trends in the AL Amyloidosis Market?

The AL Amyloidosis Global Market has been growing at a quick pace recently. The market was worth $3.11 billion in 2024 and it is projected to increase in size to $3.52 billion in 2025, reflecting a compound annual growth rate (CAGR) of 13.2%.

What are the 2025 Market Projections: Forecasted Size & Growth Rate for the AL Amyloidosis Industry?

The AL Amyloidosis Global Market Report predicts that by 2029, the market will have grown to a size of $5.74 billion, with a compound annual growth rate (CAGR) of 13.0%.

Download Your Free Sample of the 2025 AL Amyloidosis Market Report and Uncover Key Trends Now!

What are the Key Growth Drivers Fueling the AL Amyloidosis Market?

The key drivers in the al amyloidosis market are:

•Rise in incidences of mutations in blood cell DNA
•Expansion of healthcare infrastructure globally
•Growing incidence of multiple myeloma
•Introduction and application of combination therapy strategies in treatment

Global Market Segmentation: Identifying Major AL Amyloidosis Industry Segments

The AL amyloidosis market covered in this report is segmented –
1) By Treatment: Chemotherapy, Supportive Care, Surgery, Stem Cell Transplant, Targeted Therapy
2) By Drugs: Transthyretin Transport Inhibitor, Immunomodulatory Drugs, Monoclonal Antibodies, Proteasome Inhibitors, Other Drugs
3) By Route Of Administration: Intravenous, Oral
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies Subsegments:
1) By Chemotherapy: Conventional Chemotherapy Agents, High-Dose Chemotherapy
2) By Supportive Care: Pain Management, Organ-specific Supportive Care (Cardiac, Renal)
3) By Surgery: Organ Transplantation, Debulking Surgery
4) By Stem Cell Transplant: Autologous Stem Cell Transplant, Allogeneic Stem Cell Transplant
5) By Targeted Therapy: Monoclonal Antibodies, Proteasome Inhibitors, Kinase Inhibitors

Pre-order the 2025 AL Amyloidosis Global Market Report for Fast Delivery & Comprehensive Insights!

What are the emerging Trends Shaping the Future of the AL Amyloidosis Market?

The key trends in the al amyloidosis market are:

•The future of AL Amyloidosis market is likely to be shaped by advancements in diagnostic techniques.
•Technological advancements in drug delivery are becoming increasingly prevalent.
•The development of targeted therapies represents a significant emerging trend.
•The adoption of artificial intelligence in diagnosis is a critical movement shaping the market.

Who Are the Top Competitors & Leading Players in the AL Amyloidosis Market?

Major players in the al amyloidosis market are:

• Johnson & Johnson
• AbbVie Inc.
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim International GmbH
• Astellas Pharma Inc.
• Genmab A/S
• Alexion Pharmaceuticals Inc.
• Alnylam Pharmaceuticals Inc.
• Prothena Corporation plc
• BridgeBio Pharma Inc.
• Sorrento Therapeutics Inc.
• Ionis Pharmaceuticals Inc.
• Ultromics Ltd
• Neurimmune AG
• Immix Biopharma Inc.
• Oncopeptides AB
• Attralus Inc.

Regional Dominance: Which Area Leads the Global Template Market?

North America was the largest region in the AL amyloidosis market in 2024